Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:641-649

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, L. B.
Right arrow Articles by Nordestgaard, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, L. B.
Right arrow Articles by Nordestgaard, B. G.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:641-649.)
© 1998 American Heart Association, Inc.


Original Contributions

Increased Degradation of Lipoprotein(a) in Atherosclerotic Compared With Nonlesioned Aortic Intima–Inner Media of Rabbits

In Vivo Evidence That Lipoprotein(a) May Contribute to Foam Cell Formation

Lars B. Nielsen; Klaus Juul; ; Børge G. Nordestgaard

From the Department of Clinical Biochemistry, Rigshospitalet (L.B.N., K.J.), and the Department of Clinical Biochemistry, Herlev Hospital (B.G.N.), University of Copenhagen, Denmark.

Abstract—To investigate a potential role of lipoprotein(a) [Lp(a)] in foam cell formation, we have measured the degradation rates of Lp(a) and LDL in the rabbit aorta in vivo. Lp(a) (or LDL) was labeled with both 131I-TC and 125I and injected into 17 rabbits with extensive aortic atherosclerosis and into 16 rabbits without atherosclerosis. As the protein moiety of the doubly labeled lipoproteins is degraded, 131I-TC is trapped in the cell, whereas 125I diffuses out of the cell. Twenty-four hours after injection, 12 samples of the aorta and biopsies from 9 other tissues were removed. The degradation rate of Lp(a) (percent of plasma pool per gram tissue per day) was less than that of LDL in the adrenals and in the intestine. In contrast, degradation rates of Lp(a) and LDL were similar in liver, spleen, kidney, heart, lung, skeletal muscle, and adipose tissue. In nonlesioned aortic intima–inner media, the degradation rate of Lp(a) was 39% of that of LDL (t test: P <.05 in aortic arch and thoracic aorta), whereas the degradation rates of Lp(a) and LDL were similar in atherosclerotic aortic intima–inner media. Lp(a) degradation rates were markedly increased in atherosclerotic compared with nonlesioned aortic intima–inner media: 28.2±9.2x10-7% and 5.0±0.6x10-7% of the plasma pool per gram tissue per day in the intima–inner media of the proximal segment of atherosclerotic and nonlesioned aorta, respectively (t test: P <.01). These results suggest that the metabolism of Lp(a) is different from that of LDL in nonlesioned arterial intima, possibly reflecting that Lp(a) is degraded by LDL receptors in arterial intima less efficiently than LDL. The results also indicate that the degradation rate of Lp(a) is markedly increased in atherosclerotic lesions of rabbits, supporting the idea that Lp(a) contributes to foam cell formation during the development of atherosclerosis.


Key Words: atherosclerosis • cholesterol • low-density lipoprotein • macrophages




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B. G. Nordestgaard
Pentanucleotide Repeat Polymorphism, Lipoprotein(a) Levels, and Risk of Ischemic Heart Disease
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3769 - 3776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. R. Kamstrup, M. Benn, A. Tybjaerg-Hansen, and B. G. Nordestgaard
Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study
Circulation, January 15, 2008; 117(2): 176 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. M Gatto, D. R Sullivan, and S. Samman
Postprandial effects of dietary trans fatty acids on apolipoprotein(a) and cholesteryl ester transfer
Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1119 - 1124.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
G. Lippi and G. Guidi
Lipoprotein(a): from ancestral benefit to modern pathogen?
QJM, February 1, 2000; 93(2): 75 - 84.
[Abstract] [Full Text] [PDF]